Regions of Highly Recurrent Electrogram Morphology With Low Cycle Length Reflect Substrate for Atrial Fibrillation
- PMID: 36777167
- PMCID: PMC9911322
- DOI: 10.1016/j.jacbts.2022.07.011
Regions of Highly Recurrent Electrogram Morphology With Low Cycle Length Reflect Substrate for Atrial Fibrillation
Abstract
Traditional anatomically guided ablation and attempts to perform electrogram-guided atrial fibrillation (AF) ablation (CFAE, DF, and FIRM) have not been shown to be sufficient treatment for persistent AF. Using biatrial high-density electrophysiologic mapping in a canine rapid atrial pacing model of AF, we systematically investigated the relationship of electrogram morphology recurrence (EMR) (Rec% and CLR) with established AF electrogram parameters and tissue characteristics. Rec% correlates with stability of rotational activity and with the spatial distribution of parasympathetic nerve fibers. These results have indicated that EMR may therefore be a viable therapeutic target in persistent AF.
Keywords: AF, atrial fibrillation; AI, anisotropy index; CFAE, complex fractionated atrial electrogram; CLR, cycle length of the most recurrent electrogram morphology; DF, dominant frequency; EGM, electrogram; EMR, electrogram morphology recurrence; FFT, fast Fourier transform; FI, fractionation interval; FIRM, focal impulse and rotor mapping; LAA, left atrial appendage; LAFW, left atrial free wall; LAT, local activation time; OI, organization index; PLA, posterior left atrium; PV, pulmonary vein; RAA, right atrial appendage; RAFW, right atrial free wall; RAP, rapid atrial pacing; Rec%, recurrence percentage; ShEn, Shannon’s entropy; arrhythmias; atrial fibrillation; fibrosis; mapping.
© 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation.
Conflict of interest statement
Dr Arora is supported by National Institutes of Health grants R01 HL093490; R01 HL140061; an AHA Strategically Focused Research Networks AF Center grant; and by the NIH Center for Accelerated Innovations at Cleveland Clinic (NCAI-CC). Dr Arora has ownership interest in Rhythm Therapeutics. Dr Pfenniger is supported by grant KL2TR001424. All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures







References
-
- Heijman J., Guichard J.B., Dobrev D., Nattel S. Translational challenges in atrial fibrillation. Circ Res. 2018;122:752–773. - PubMed
-
- Schotten U., Verheule S., Kirchhof P., Goethe A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91:265–325. - PubMed
-
- Haissaguerre M., Jais P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–666. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous